Hydrochlorothiazide/Metoprolol Succinate
琥珀酸美托洛尔/氢氯噻嗪
Report date: 2022/04/07 09:13:28
Base Information
Drug NameHydrochlorothiazide/Metoprolol Succinate
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2006/08/28
Country/Territory
CombinationsYes HydrochlorothiazideMetoprolol Succinate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAstrazeneca PlcConcordia
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A